We are proud to announce that Richard Baltz has joined MicroMGx as a Scientific Advisor. Dr. Baltz is a both a pioneer and thought leader in #naturalproducts discovery. He led the Eli Lilly Molecular Genetics department and helped establish Lilly as a world leader in genetic engineering of industrial actinomycetes. Later, he worked with Cubist Pharmaceuticals to launch the last new antibiotic – Cubicin. Richard’s knowledge of microbial strain collections is unsurpassed, knowledge that will be quite useful as we continue to build the world’s largest metabologenomics library. Dr. Baltz was recently interviewed about how the world can solve the Antimicrobial Resistance problem.  You can view that interview here.

We will continue to add world-class Science/Industry Advisors to MicroMGx. Their objectivity, experience, expertise, and networks will increase the quality of our MGX Library, the speed of our commercialization, and the strength of our overall strategy.